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Abstract
Background: Few cases of Q fever osteoarticular infection have been reported, with chronic osteomyelitis as the
most common manifestation of Q fever osteoarticular infection. Here we present the case of a sternoclavicular joint
infection caused by Coxiella burnetii and localized by positron emission tomography scanning.
Case presentation: A 67-year-old French man from south France was hospitalized for fever and confusion. An
examination revealed subclavicular and axillary lymph node enlargement. Computed tomography scanning and
transesophageal echocardiogram were normal, and magnetic resonance imaging scanning did not reveal signs of
infection. An immunofluorescence assay of an acute serum sample was positive for C. burnetii and he was treated
with 200 mg doxycycline for 21 days. An immunofluorescence assay of convalescent serum sampled after 2 months
revealed very high C. burnetii antibody titers. To localize the site of the infection, we performed positron emission
tomography scanning, which revealed intense fluorodeoxyglucose uptake in his right sternoclavicular joint;
treatment with 200 mg oral doxycycline daily and 200 mg oral hydroxychloroquine three times daily for 18
months was initiated.
Conclusions: Q fever articular infections may be undiagnosed, and we strongly urge the use of positron
emission tomography scanning in patients with high C. burnetii antibody titers to localize the site of C.
burnetii infection.
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Background
Q fever is a potentially life-threatening worldwide zoonosis
caused by an obligate intracellular bacterium, Coxiella bur-
netii [1]. Infective endocarditis is the most frequent Q fever
chronic infection, followed by vascular, osteoarticular, hepa-
titis and pulmonary infection [1]. To date, few cases of Q
fever osteoarticular infection have been reported in the lit-
erature; they include osteomyelitis, spondylodiscitis and
two cases of tenosynovitis [2, 3]. In fact, only seven (2 %)
osteoarticular infections were detected in a large serologic
study which included more than 1300 cases of Q fever that
extended over 14 years [4], and 11 (0.7 %) cases in a recent
7-year study which included more than 1400 cases [5].
Osteomyelitis is the most common manifestation of Q fever
osteoarticular infection, followed by vertebral spondylodis-
citis and paravertebral abscess [1, 2]. C. burnetii has also
been implicated in a prosthetic joint infection [3], while
two cases of tenosynovitis have been reported [6].
Q fever osteoarticular infection can easily go undiag-
nosed because of the long evolution of articular involve-
ment, which is accompanied by a low level of laboratory
and inflammatory signs [1]. However, in recent years,
positron emission tomography (PET) scanning has been
successfully used for the identification of infectious foci
in C. burnetii infections [1, 7], and the use of PET scan-
ning was recently proposed as a complementary tool for
patients with high C. burnetii antibody titers in order to
localize the site of C. burnetii infection [1, 8]. Here we
present a case of a sternoclavicular joint infection caused
by C. burnetii, localized by PET scanning.
Case presentation
A 67-year-old French man from south France was admitted
to our hospital approximately 1 year ago (February 2015)
with fever (39 °C) and confusion. He mentioned in-
creased alcohol consumption. An examination revealed
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subclavicular and axillary lymph node enlargement. More-
over, he presented cerebellar ataxia, with loss of equilibrium
and difficulty walking. Laboratory values revealed elevated
C-reactive protein (216 mg/L) and liver enzyme levels (as-
partate aminotransferase 100 IU/L, alanine aminotransfer-
ase 69 IU/L, gamma-glutamyl transferase 125 IU/L) and
hyponatremia (sodium 123 mEq/L). A liver ultrasound
showed hepatomegaly. Computed tomography (CT) scan-
ning was normal and magnetic resonance imaging (MRI)
scanning did not reveal signs of infection. Treatment with
ceftriaxone and levofloxacin was introduced, but his fever
did not resolve. A serum sample was sent to our laboratory
in Marseille and an immunofluorescence assay (IFA) was
positive for C. burnetii; phase I titers for immunoglobulin
(Ig) G, IgM, and IgA were 400, 200 and 0, respectively, and
phase II titers were 400, 200, and 0, respectively. The diag-
nosis of acute Q fever infection was made and he was
treated with 200 mg oral doxycycline daily for 21 days. IgG
anticardiolipin (aCL) antibody levels in the serum sample
were very high (216 GPLU), and we suspected valvular
heart disease and a possible progression to Q fever endo-
carditis [5]. However, a transesophageal echocardiogram
was normal. After 2 months we obtained a second serum
sample and phase I IFA titers for IgG, IgM, and IgA were
25,600, 0 and 0, respectively, and phase II titers were
25,600, 0, and 0, respectively. Both serum samples were
negative for C. burnetii by quantitative polymerase chain
reaction (qPCR) for the IS1111 and the IS30A spacers [9].
A localized C. burnetii infection was suspected; lymph node
biopsies were performed that were negative for C. burnetii
by molecular assays. For each sample, we verified the
quality of DNA handling and extraction of samples by
qPCR for a housekeeping gene encoding beta-actin [10].
The lymph node biopsies were also negative for C. burnetii
by immunohistochemical analysis using a monoclonal anti-
body against C. burnetii with an immunoperoxidase kit
[11]. Moreover, the lymph nodes were also tested by fluor-
escent in situ hybridization (FISH) [12], which was also
negative. To localize the site of the infection we performed
PET scanning, which revealed intense fluorodeoxyglucose
uptake in his right sternoclavicular joint (Fig. 1). A diagno-
sis of sternoclavicular joint infection by C. burnetii was
made, and treatment with 200 mg oral doxycycline daily
and 200 mg oral hydroxychloroquine three times daily for
18 months was introduced. After 6 months follow-up, the
outcome was favorable, with a four-fold decrease in the
phase I and phase II IFA titers for IgG.
Discussion
We report a case of Q fever sternoclavicular joint infection
diagnosed through serology and localized using PET scan-
ning. PET scanning has been previously used for the identi-
fication of infectious foci in C. burnetii vascular infections
[7], in the bone marrow [13], in the liver [14], and recently
two cases of arthritis and subacromial bursitis caused by C.
burnetii were also localized [1]. In this case we suspected a
localized C. burnetii infection because of the very high IFA
titers and IgG-aCL levels [15]. In fact, persistent localized
infections have been associated with increased levels of IgG
and IgA antibodies [16]. However, echocardiography did
not reveal signs of endocarditis and lymph nodes were
negative for C. burnetii. As Q fever articular infections
Fig. 1 18F-fluorodeoxyglucose positron emission tomography computed tomography in a patient with Coxiella burnetii sternoclavicular joint
infection. The high fluorodeoxyglucose uptake (arrows) is observed at the level of the sternoclavicular joint
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present a long evolution of articular involvement, accom-
panied by a low level of inflammatory signs, and can easily
remain undiagnosed [2], the PET scanner was a valuable
tool for the identification and the localization of the infec-
tious foci of C. burnetii in the sternoclavicular joint. Al-
though we did not test the sternoclavicular joint to confirm
the diagnosis, a localized infection with C. burnetii is asso-
ciated with high antibody titers against C. burnetii [17]. For
our patient the only fluorodeoxyglucose uptake was in the
right sternoclavicular joint indicating that this was the site
of fixation.
Epidemiological patterns of Q fever osteoarticular in-
fections may consist of sporadic cases that are difficult
to diagnose. As with the majority of Q fever osteoarticu-
lar infections, our patient was an adult man more than
50-years old [2]. Although most described cases with
osteoarticular infections present swelling and arthralgia
without inflammatory signs [2, 6], our patient did not
complain of arthralgia. Despite limited data concerning
therapeutic strategies for Q fever osteoarticular infec-
tions, a regimen of doxycycline and hydroxychloroquine
for 18 months has been suggested [1, 2]. Our patient
was treated with a course of doxycycline and hydroxy-
chloroquine for 18 months.
Conclusion
In conclusion, we confirm the efficacy of PET scanning
for the identification of infectious foci in C. burnetii in-
fections and we strongly urge its use in patients with
high C. burnetii antibody titers in order to localize the
site of the C. burnetii infection.
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